These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
8. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Shaheen NJ; Inadomi JM; Overholt BF; Sharma P Gut; 2004 Dec; 53(12):1736-44. PubMed ID: 15542506 [TBL] [Abstract][Full Text] [Related]
9. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Fayter D; Corbett M; Heirs M; Fox D; Eastwood A Health Technol Assess; 2010 Jul; 14(37):1-288. PubMed ID: 20663420 [TBL] [Abstract][Full Text] [Related]
10. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW; Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191 [TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
12. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. Hirst NG; Gordon LG; Whiteman DC; Watson DI; Barendregt JJ J Gastroenterol Hepatol; 2011 Feb; 26(2):247-54. PubMed ID: 21261712 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy. Menon D; Stafinski T; Wu H; Lau D; Wong C BMC Gastroenterol; 2010 Sep; 10():111. PubMed ID: 20875123 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Hur C; Nishioka NS; Gazelle GS Dig Dis Sci; 2003 Jul; 48(7):1273-83. PubMed ID: 12870783 [TBL] [Abstract][Full Text] [Related]
16. A guide for surveillance of patients with Barrett's esophagus. Provenzale D; Kemp JA; Arora S; Wong JB Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136 [TBL] [Abstract][Full Text] [Related]
17. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
18. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. Gray J; Fullarton GM Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112 [TBL] [Abstract][Full Text] [Related]
19. Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. Gordon LG; Hirst NG; Mayne GC; Watson DI; Bright T; Cai W; Barbour AP; Smithers BM; Whiteman DC; Eckermann S; J Gastrointest Surg; 2012 Aug; 16(8):1451-61. PubMed ID: 22644445 [TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]